绿竹生物-B（02480.HK）今日盘中大涨9.47%，引起市场广泛关注。该股价的显著上涨与公司最新发布的中期业绩报告密切相关。
根据绿竹生物-B发布的截至2025年6月30日止六个月业绩报告，公司净亏损为7757万元人民币，同比收窄29.4%。尽管公司仍处于亏损状态，但亏损幅度的显著收窄被投资者视为积极信号。与此同时，报告显示公司其他收入为485万元人民币，同比下降50.2%；每股基本亏损为0.39元。
分析人士指出，尽管绿竹生物-B的收入有所下降，但净亏损的大幅收窄表明公司在成本控制和运营效率方面可能取得了进展。这一财务状况的改善可能增强了投资者对公司未来盈利能力的信心，从而推动股价上涨。然而，投资者仍需关注公司未来的业务发展和盈利能力的持续改善情况。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.